AKESOgen
About:
AKESOgen is a biomarker, genomics, and pharmacogenomics contract research organization.
Website: http://www.akesogen.com/
Twitter/X: Akesogen
Top Investors: Georgia Research Alliance
Description:
AKESOgen is an integrated genomics, genetics and biobanking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing and research. Based in greater Atlanta, GA, the company’s initial focus has been oncology and personalized medicine. AKESOgen’s Research Services and Clinical/Regulatory Services include providing high-throughput biomarker profiling, cytogenomic arrays, sequencing (both NGS and Sanger), genotyping and epigenomic analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation) to CLIA/GLP standards. Their expertise in genomics and process control as well as their customer commitment make AKESOgen an ideal partner to execute and deliver on your projects.
$1.85M
$1M to $10M
Norcross, Georgia, United States
2010-01-01
info(AT)akesogen.com
Mark Bouzyk, Robert Boisjoli
11-50
2019-04-03
Private
© 2025 bioDAO.ai